Navigation Links
VCU Massey Cancer Center study shows enzyme linked to spread of breast cancer cells

Researchers at the Virginia Commonwealth University Massey Cancer Center have found a new signaling component that influences movement of human breast cancer cells toward epidermal growth factor.

In the August issue of the Journal of Biological Chemistry, researchers showed that epidermal growth factor, which plays a critical role in breast cancer progression, stimulates sphingosine kinases - SphK1 and SphK2 - a family of enzymes that forms the potent lipid mediator, sphingosine-1-phosphate, and that breast cancer cells are unable to move without these kinases.

"If we understood how tumor cells spread or metastasize, we would be able to design better tools to help treat cancers," said lead author Sarah Spiegel, Ph.D., chair and professor in the VCU Department of Biochemistry and co-leader of the Massey Cancer Center Cell Signaling program.

Spiegel, who is internationally recognized for her pioneering work on new lipid mediators that regulate cell growth and cell death, and her colleagues, first discovered the role of sphingosine-1-phosphate in cell growth regulation nearly a decade ago. While researchers know that SphK1 is stimulated by multiple growth factors, less is known about how SphK2 is regulated. Spiegel and her team are continuing this work to better understand the functions of these enzymes.

"Our work suggests that sphingosine kinases are potential new targets in cancer therapy," she said.


'"/>

Source:Virginia Commonwealth University


Page: 1

Related biology news :

1. Massey Cancer Center researcher helps to identify a piece of the cancer puzzle
2. VCU Massey Cancer Center researchers identify a new class of anti-cancer drugs based on platinum
3. Massey researchers induce cell death in leukemia
4. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
5. Jump-starting T Cells In Skin Cancer
6. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
7. Fox Chase Cancer Center scientists identify immune-system mutation
8. Breakthrough Microarray-based Technology for the Study of Cancer
9. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
10. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
11. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... 14, 2018 , ... From reconstruction of craniofacial syndrome effects, ... understanding of congenital heart defects, 3-D printing is providing exciting approaches to more ... Birth Defects Research (DOI: 10.1002/bdr2.1367). , The special issue ...
(Date:8/7/2018)... EDWARDSVILLE, Ill. (PRWEB) , ... August 06, 2018 ... ... corn growing in front of The NCERC at Southern Illinois University Edwardsville’s University ... corn, but also grain sorghum and sweet sorghum. These three feedstocks represent conventional ...
(Date:8/2/2018)... ... August 02, 2018 , ... The ... innovator Boston Heart Diagnostics to its Lifestyle Medicine Corporate Roundtable, a group of ... care system and a sustainable world. , Boston Heart is transforming the ...
Breaking Biology News(10 mins):
(Date:8/14/2018)... ... August 14, 2018 , ... The growing interest ... of the Chinese Association of Orthopaedic Surgeons (CAOS) held in partnership with the ... Development , Beijing, and Invibio Biomaterial Solutions partnered to demonstrate the ...
(Date:8/9/2018)... ... August 08, 2018 , ... ... was developed and is continually updated by a talented scientific team that includes ... service provides: , 1. Information on the medical impact of a patient’s ...
(Date:8/9/2018)... , ... August 09, 2018 , ... ... revenue cycle management (RCM), patient engagement and analytics software and services for physician ... the highest in its twenty-year history. After back-to-back record quarters in Q2 and ...
(Date:8/7/2018)... BOSTON (PRWEB) , ... August 06, 2018 , ... ... life sciences and diagnostics companies, announces the placement of Dr. Paul Harney as ... delivering Prescient’s North America growth strategy and enhancing client satisfaction. He was also ...
Breaking Biology Technology: